MPCUK

Dr Neil Steven is a consultant in Medical Oncology specialising in treating people with advanced melanoma and Merkel cell cancer.  He has extensive experience in the use of immune and targeted therapies and has built a multi-disciplinary framework for managing the complex immune related adverse events which arise from such treatment.  This is a developing area of collaborative academic research.

Dr Steven specialises in the design and execution of clinical trials of immune therapy for malignant disease.  He works as part of a multidisciplinary framework in Birmingham including the CR-UK Clinical Trials Unit (CRCTU) and the Cancer Immunology and Immunotherapy Centre.  He has a particular scientific interest in the immunology of cancers carrying viruses, such as Epstein-Barr virus (EBV) and Merkel cell polyomavirus (MCV).  He is conducting trials for people with EBV+ nasopharyngeal carcinoma and Merkel cell carcinoma. 

 As Deputy Director of the CRCTU, Dr Steven plays a key role in the strategic and scientific development of early phase clinical trials for solid cancers.